(Q43984395)

English

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation

scientific article

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

28 November 2017

Early cyclosporine withdrawal from a sirolimus-based regimen results in better renal allograft survival and renal function at 48 months after transplantation (English)

1 reference

Europe PubMed Central

28 November 2017

1 reference

based on heuristic

inferred from title

Giovanni Stallone

9

1 reference

Europe PubMed Central

28 November 2017

author name string

Rainer Oberbauer

1

1 reference

Europe PubMed Central

28 November 2017

Giuseppe Segoloni

2

1 reference

Europe PubMed Central

28 November 2017

Josep M Campistol

3

1 reference

Europe PubMed Central

28 November 2017

Henri Kreis

4

1 reference

Europe PubMed Central

28 November 2017

Alfredo Mota

5

1 reference

Europe PubMed Central

28 November 2017

Joseph Lawen

6

1 reference

Europe PubMed Central

28 November 2017

Graeme Russ

7

1 reference

Europe PubMed Central

28 November 2017

Josep M Grinyó

8

1 reference

Europe PubMed Central

28 November 2017

Anders Hartmann

10

1 reference

Europe PubMed Central

28 November 2017

Jose R Pinto

11

1 reference

Europe PubMed Central

28 November 2017

Jeremy Chapman

12

1 reference

Europe PubMed Central

28 November 2017

James T Burke

13

1 reference

Europe PubMed Central

28 November 2017

Yves Brault

14

1 reference

Europe PubMed Central

28 November 2017

John F Neylan

15

1 reference

Europe PubMed Central

28 November 2017

Rapamune Maintenance Regimen Study Group

16

1 reference

Europe PubMed Central

28 November 2017

publication date

1 January 2005

1 reference

Europe PubMed Central

28 November 2017

Transplant International

1 reference

Europe PubMed Central

28 November 2017

18

1 reference

Europe PubMed Central

28 November 2017

1

1 reference

Europe PubMed Central

28 November 2017

22-28

1 reference

Europe PubMed Central

28 November 2017

Sirolimus does not exhibit nephrotoxicity compared to cyclosporine in renal transplant recipients.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

A worldwide, phase III, randomized, controlled, safety and efficacy study of a sirolimus/cyclosporine regimen for prevention of acute rejection in recipients of primary mismatched renal allografts

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Sirolimus allows early cyclosporine withdrawal in renal transplantation resulting in improved renal function and lower blood pressure

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Long-term benefits with sirolimus-based therapy after early cyclosporine withdrawal

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Post-transplant renal function in the first year predicts long-term kidney transplant survival

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Poor predictive value of serum creatinine for renal allograft loss

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Everolimus for the prevention of allograft rejection and vasculopathy in cardiac-transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Randomized trial of tacrolimus + mycophenolate mofetil or azathioprine versus cyclosporine + mycophenolate mofetil after cadaveric kidney transplantation: results at three years.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Sirolimus in association with mycophenolate mofetil induction for the prevention of acute graft rejection in renal allograft recipients

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Kidney transplantation without calcineurin inhibitor drugs: a prospective, randomized trial of sirolimus versus cyclosporine

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

A BLINDED, LONG-TERM, RANDOMIZED MULTICENTER STUDY OF MYCOPHENOLATE MOFETIL IN CADAVERIC RENAL TRANSPLANTATION

1 reference

https://api.crossref.org/works/10.1111%2FJ.1432-2277.2004.00052.X

21 January 2018

Identifiers

10.1111/J.1432-2277.2004.00052.X

1 reference

Europe PubMed Central

28 November 2017

1 reference

Europe PubMed Central

28 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43984395&oldid=2105302415"